CREON MINIMICROSPHERES® 10

Traducción no disponible. Texto original, idioma: inglés.

For replacement therapy where digestion is not adequate due to pancreatic exocrine insufficiency.

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias · 2013-01-10

Traducción no disponible. Texto original, idioma: inglés.

Cautions and Warnings : Very high doses of pancreatic enzymes may increase levels of uric acid in the blood (hyperuricaemia) and/or urine (hyperuricosuria). Fibrosing colonopathy (described as abnormal narrowing of the colon and bowel) has been reported in patients with cystic fibrosis taking high doses of pancreatic enzymes. As a precaution, consult your doctor if you experience any unusual abdominal symptoms or any change in abdominal symptoms, especially if taking in excess of 10,000 units of lipase/kg body weight/day or more that 4,000 units of lipase/gram fat intake. Creon should not be used during pregnancy or lactation unless clearly necessary. If required during pregnancy and lactation, Creon should be used in doses sufficient to provide adequate nutritional status. As with all currently marketed porcine pancreatin products, Creon is sourced from pancreatic tissue from swine used for food consumption. Although the risk that Creon will transmit an infectious agent to humans has been reduced by the testing and inactivation of certain viruses during manufacturing, there is a theoretical risk for transmission of viral disease, including diseases caused by novel or unidentified viruses. The presence of porcine viruses that might infect humans cannot be definitely excluded. However, no cases of transmission of an infectious illness associated with the use of porcine pancreatic extracts have been reported, whereas they have been used for a long time.

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias · 2013-01-10